Navigation Links
New study of the world's smallest elephant

The world's smallest elephant species, the newly described Bornean elephant, will be the focus of a Cardiff University study in Sabah, Malaysia for the next three years.

The Bornean elephant has recently been confirmed as a separate sub-species, dramatically increasing its importance for biodiversity. Bornean elephants are the world's most endangered member of the elephant family with an estimated 1,100 - 1,500 surviving in the wild.

The Cardiff School of Biosciences study led by Professor Michael Bruford and funded by the Department of Environment, Food and Rural Affairs, will provide the Sabah Wildlife Department with a range of essential conservation and management information concerning the ecology, genetics, social structure, dispersal and conflicts with agriculture.

Dr Benoît Goossens who will carry out the research, said the need for the project was identified by wildlife authorities in Sabah during a previous Darwin Initiative grant to study orangutans. He said: "There is clearly an urgent need to undertake sound conservation action. Our work will provide information that is currently lacking, including identification of priority areas for the species that should be kept under forest cover.

"The project will also include training for Malaysian MSc student, Ms Nurzhafarina Othman in population biology and conservation genetics; and training for governmental and non-governmental organisations as well as representatives from the private sector on wildlife monitoring techniques."

Project partners are the Sabah Wildlife Department, Kinabatangan Orang Utan Conservation Project and the Institute for Tropical Biology and Conservation at Universiti Malaysia Sabah.


'"/>

Source:Cardiff University


Page: 1

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... 6, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, and ... a five (5) year funding commitment by Securus ... the rehabilitation and reentry support to more inmates ... in 2004, the Prison Entrepreneurship Program (PEP) is ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... media products engineered to radically streamline culture processes, minimize processing time, significantly ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
(Date:12/7/2016)... /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces webcast ... the Company,s Annual and Special Meeting. The ... on Thursday, December 15, 2016 at Mount Royal ... 4825 Mount Royal Gate SW, Calgary, Alberta ... and management information circular, containing the matters to be considered ...
Breaking Biology Technology: